These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2414585)

  • 1. Increased cardiovascular responses to norepinephrine and calcium antagonists in essential hypertension compared with normotension in humans.
    Aoki K; Sato K; Kawaguchi Y
    J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S182-6. PubMed ID: 2414585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiological background for the use of calcium antagonists.
    Aoki K; Sato K
    J Cardiovasc Pharmacol; 1985; 7 Suppl 4():S28-32. PubMed ID: 2412008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the hemodynamic effects of five calcium channel blockers at rest and during exercise in essential hypertension.
    Omvik P; Lund-Johansen P
    Ann Clin Res; 1988; 20 Suppl 48():23-30. PubMed ID: 3250315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of sodium balance and calcium channel blocking drugs on blood pressure responses.
    Anderson GH; Howland T; Domescek R; Streeten DH
    Hypertension; 1987 Sep; 10(3):239-48. PubMed ID: 3623678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium.
    Saïag B; Milon D; Bentue-Ferrer D; Allain H; Rault B; Van den Driessche J
    Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):255-69. PubMed ID: 8008975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age hemodynamics and exercise in essential hypertension: difference between beta-blockers and dihydropyridine calcium antagonists.
    Lund-Johansen P
    J Cardiovasc Pharmacol; 1989; 14 Suppl 10():S7-13. PubMed ID: 2483573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nifedipine and diltiazem on hemodynamic responses at rest and during exercise in hypertensive patients.
    Yamakado T; Oonishi N; Nakano T; Takezawa H
    Jpn Circ J; 1985 Apr; 49(4):415-21. PubMed ID: 4009928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of calcium antagonists in the treatment of essential hypertension.
    Klein W; Brandt D; Vrecko K; Härringer M
    Circ Res; 1983 Feb; 52(2 Pt 2):I174-81. PubMed ID: 6831651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of acute mild hypercalcemia or of the calcium antagonist nifedipine on cardiovascular responsiveness to norepinephrine or angiotensin II in normal humans.
    Beretta-Piccoli C; Bianchetti MG; Weidmann P; Boehringer K; Link L; Morton JJ
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S306-12. PubMed ID: 6184559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the cardiovascular effects of trans-diclofurime with different types of calcium antagonists in conscious spontaneously hypertensive rats.
    Petty MA; Mir AK
    Br J Pharmacol; 1988 Aug; 94(4):1218-24. PubMed ID: 3207982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nilvadipine on the cardiovascular system in experimental animals.
    Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
    Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term haemodynamic effects of amlodipine at rest and during exercise in essential hypertension.
    Lund-Johansen P; Omvik P; White W; Digranes O; Helland B; Jordal O; Stray T
    J Hypertens; 1990 Dec; 8(12):1129-36. PubMed ID: 1962802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of calcium membrane blockers on in vivo vasoconstrictor properties of norepinephrine, angiotensin II and vasopressin.
    Goldberg JP; Schrier RW
    Miner Electrolyte Metab; 1984; 10(3):178-83. PubMed ID: 6727804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nisoldipine. Central haemodynamics at rest and during exercise in essential hypertension: acute and chronic studies.
    Omvik P; Lund-Johansen P; Haugland H
    J Hypertens; 1988 Feb; 6(2):95-103. PubMed ID: 3351300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of calcium antagonist, angiotensin-converting enzyme inhibitors and beta-blocker on hemodynamic and sympathetic nerve responses to exercise in essential hypertension].
    Fujiwara S; Arita M; Ueno Y; Shiotani M; Nakatsu C; Nakamura Y; Hano T; Nishio I; Masuyama Y
    J Cardiol; 1991; 21(1):115-24. PubMed ID: 1687786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute hypotensive, hemodynamic effects of long-term treatment with niludipine, a Ca2+-antagonist, in patients with essential hypertension. Niludipine monotherapy and combination with a beta-blocker and a diuretic).
    Aoki K; Sato K
    Arzneimittelforschung; 1982; 32(9):1141-5. PubMed ID: 6756418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of lercanidipine and nifedipine GITS on plasma norepinephrine in chronic treatment of hypertension.
    Fogari R; Mugellini A; Zoppi A; Corradi L; Rinaldi A; Derosa G; Preti P
    Am J Hypertens; 2003 Jul; 16(7):596-9. PubMed ID: 12850395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium and blood pressure regulation in normal and hypertensive subjects.
    Bianchetti MG; Beretta-Piccoli C; Weidmann P; Link L; Boehringer K; Ferrier C; Morton JJ
    Hypertension; 1983; 5(4 Pt 2):II57-65. PubMed ID: 6345376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of sodium balance and calcium channel-blocking drugs on plasma aldosterone responses to infusion of angiotensin II in normal subjects and patients with essential hypertension.
    Anderson GH; Howland T; Domschek R; Streeten DH
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1126-35. PubMed ID: 3760114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin blockade or calcium antagonists improve endothelial dysfunction in hypertension: studies in perfused mesenteric resistance arteries.
    Dohi Y; Criscione L; Pfeiffer K; Lüscher TF
    J Cardiovasc Pharmacol; 1994 Sep; 24(3):372-9. PubMed ID: 7528292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.